课题基金 / 基金详情

New emerging team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies

New emerging team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies
夏勒瓦-萨格奈常染色体隐性痉挛性共济失调 (ARSACS) 的新兴团队:从模型到治疗策略
批准号:
247550
负责人:
Brais Bernard
金额:
$91.06万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-08-01 至 2016-08-01

项目摘要

项目成果

Brais Bernard的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a progressive neurological disease in which certain types of neurons die and patients thus have problems with balance and coordination. It was originally identified in the Charlevoix an
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Designing a toolbox of paradigmatic treatments for a targeted molecular medicine approach to autosomal-recessive ataxias
  • 批准号:
    430840
  • 项目类别:
    Operating Grants
  • 资助金额:
    $16.39万
  • 财政年份:
    2020
  • 负责人:
    Brais Bernard
  • 依托单位:
PROSPAX: an integrated multimodal progression chart in spastic ataxias
  • 批准号:
    406801
  • 项目类别:
    Operating Grants
  • 资助金额:
    $16.35万
  • 财政年份:
    2019
  • 负责人:
    Brais Bernard
  • 依托单位:
PREPARE: Preparing for therapies in autosomal recessive ataxias